Key opinion leaders discuss the disease state, treatment landscape, and future considerations for treating patients with myelodysplastic syndrome (MDS).
EP. 1: Prevalence and Types of Myelodysplastic Syndromes (MDS)
Ryan Haumschild, PharmD, MS, MBA, leads a discussion surrounding myelodysplastic syndrome (MDS).
EP. 2: Risk Factors for Developing MDS
Medical experts provide an overview on potential risk factors leading to MDS.
EP. 3: The Impact of MDS Diagnosis on Patients’ Quality of Life
Zahra Mahmoudjafari, PharmD, BCOP, DPLA, provides insight on the impact myelodysplastic syndrome has on patients’ quality of life.
EP. 4: Excluding Differential Diagnoses: MDS vs AML
Robert Mancini, PharmD, BCOP, FHOPA, highlights differentiating diagnoses similar to myelodysplastic syndrome and discusses the International Prognostic Scoring System (IPSS).
EP. 5: Goals of Treatment for Patients with MDS
Experts outline treatment goals for patients diagnosed with MDS.
EP. 6: Utilizing Supportive Care in Patients with MDS
A panel of medical experts discuss supportive care needs for patients with myelodysplastic syndrome.
EP. 7: Evaluating MDS Treatment Pathways
Drs Mahmoudjafari and Mancini evaluate MDS treatment pathways and offer potential needs for switching treatment strategies.
EP. 8: Monitoring for Treatment Toxicity in Patients with MDS
Key opinion leaders discuss how quality of life is impacted by refractory anemia and treatment toxicity in patients with MDS.
EP. 9: Role of Oral Agents in MDS Treatment Strategy
Dr Mahmoudjafari shares considerations for incorporating oral agents into MDS treatment landscape.
EP. 10: Barriers to Optimal Care for Patients Diagnosed with MDS
Dr Mancini navigates challenges inhibiting patients to receive optimal care amid diagnosis of MDS.
EP. 11: NCCN Guidelines Directing MDS Treatment Strategies
Drs Mancini and Mahmoudjafari discuss NCCN Guidelines affecting treatment strategies for patients with MDS.
EP. 12: Trajectory of MDS Treatment Landscape
The panel of experts provide their closing thoughts, highlighting unmet needs and treatments on the horizon for MDS.
2 Clarke Drive Cranbury, NJ 08512